In another study using a melanoma and fibrosarcoma mouse models, metformin treatment increases mitochondrial reactive oxygen species (mtROS) production in CD8+ TILs, which enhances Glut-1 cell surface expression and activates Nrf2 in CD8+ TILs. This evidence concerns the gene CD8A and melanoma.